Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I FCAR-CD20 (CART001) in refractory CD20-positive B-cell non-Hodgkin lymphoma
jRCT1080224690Phase 1Completed
- Sponsor
- National Cancer Center Hospital East
- Start
- May 2019
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of CART001 in mature B-cell lymphoma, sponsored by National Cancer Center Hospital East. Started May 2019; status: completed.
02
Drugs
CART001
03
Conditions
mature B-cell lymphoma
Beyond the preview
Go deeper on jRCT1080224690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224690.